ISSN: 2475-3173

Cancer du col de l'utérus : accès libre

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Late Relapse of Germ Cell Tumours Following Prior Chemotherapy or Surgery-Only Treatment

John Bardeen

Late relapse of germ cell tumors (GCTs) following prior chemotherapy or surgery-only treatment refers to the recurrence of GCTs after an initial period of remission. This phenomenon poses a challenge in the management and long-term follow-up of patients with GCTs. The aim of this study was to investigate the clinical characteristics, treatment outcomes, and prognostic factors associated with late relapse in GCT patients who had previously received chemotherapy or surgery-only treatment. A comprehensive review of medical records was conducted to identify patients who experienced late relapse. The key findings of this study highlight the importance of long-term surveillance and close monitoring of GCT patients even after apparent remission. Additionally, the study identified several potential prognostic factors that may aid in the identification of patients at higher risk of late relapse, facilitating early detection and intervention.